Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate permanent brachytherapy in early-stage prostate cancer: A matched subset analysis

Molecular Urology

Volumn 4, Issue 3, 2000, Pages 155-159+161

  Sylvester, J ^a   Blasko, J C ^a   Grimm, P D ^a   Meier, R ^a   Cavanagh, W ^a   Garzotto, M ^a   Moul, J ^a   Fair, W ^a  

^a Puget Sound Tumor Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

BEAM THERAPY; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER STAGING; CONFERENCE PAPER; CONTROLLED STUDY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SCORING SYSTEM; TREATMENT OUTCOME;

ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; NEOADJUVANT THERAPY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0033755608     PISSN: 10915362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
2. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer
3. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group
4. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31
5. Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: A prospective randomized study
6. Prostate brachytherapy: Treatment strategies
7. Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: A preliminary report of 434 patients
8. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
9. Does brachytherapy have a role in the treatment of prostate cancer?
10. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma
11. Conformal radiation approaches to the treatment of early prostate cancer: Techniques, outcomes and pitfalls
12. Interstitial implantation techniques in prostate cancer
13. Neoadjuvant androgen ablation combined with external beam radiation therapy and permanent interstitial brachytherapy boost in localized prostate cancer
14. Should brachytherapy be considered a therapeutic option in localized prostate cancer?
15. Brachytherapy and organ preservation in the management of carcinoma of the prostate
16. Studies on prostatic cancer I: The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate
17. Adjuvant tamoxifen in the management of operable breast cancer:The Scottish Trial. Report from the Scottish Cancer Trials Office (MRC), Edinburgh
18. Tamoxifen for early breast cancer: An overview of the randomised trials
19. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors
20. Tamoxifen in the treatment of breast cancer
21. Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy
22. Potential for neoadjuvant hormonal therapy with brachytherapy for prostate cancer
23. Palladium- 103 brachytherapy for prostate carcinoma
24. Transient elevation of serum prostate-specific antigen following 1251/103Pd brachytherapy for localized prostate cancer
25. Conformal brachytherapy boost to external beam irradiation for localized high risk prostate cancer